NAMSA(r) Launches "Uniquely IVD" Development Services to Expedite in Vitro Diagnostic Technology Commercialization Efforts for Global Manufacturers
Monday, July 30, 2018 - 07:50
in Mathematics & Economics
NAMSA(r), the world's only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services, announced today the launch of its in vitro diagnostic (IVD) development business to provide global manufacturers a proven resource for expedited commercialization outcomes delivered via NAMSA's "Uniquely IVD" regulatory, quality and clinical research services.